MedTrace Logo

Effects of Inulin and Arabinoxylan on Satiety, Energy/Food Intake and Changes in the Human Gut Microbiota

NCT02846454 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2018-05-11

No results posted yet for this study

Summary

This proposed randomized, double blinded 12 week crossover human feeding study aims to investigate the effects of consuming a composite drink of inulin and arabinoxylan on satiety by measuring appetite biomarkers such as subjective satiety, energy/food intake and changes in the human gut microbiota in healthy weight males (22 to 24.9kg/m2)

Conditions

  • Overweight and Obesity

Interventions

OTHER

inulin

Investigate the satiating effects of consuming 4g/d inulin in 2 daily doses of 2g

OTHER

arabinoxylan

Investigate the satiating effects of consuming 4g/d arabinoxylan in 2 daily doses of 2g

Sponsors & Collaborators

  • University of Reading

    lead OTHER

Principal Investigators

  • Mike Proven, PhD · Ethics committee Co-ordinator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-07-01
Completion
2018-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02846454 on ClinicalTrials.gov